Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) announced that its President and CEO, Howard Robin, will present at the 41^st Annual J.P. Morgan Healthcare Conference in San Francisco on January 11, 2023, at 8:15 a.m. PT. The presentation can be accessed via a Webcast, available on Nektar's Investor Events Calendar until February 11, 2023.

Nektar is a biopharmaceutical firm focusing on oncology and immunology, with a strong R&D pipeline. More information about the event and Nektar’s drug development can be found on their website.

SAN FRANCISCO, Jan. 4, 2023 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 41^st Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 8:15 a.m. Pacific Time. The presentation and Q&A session will be accessible via a Webcast through a link posted on the Investor Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events. This webcast will be available for replay until February 11, 2023.

About Nektar

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology and immunology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

For Media:
David Rosen of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-therapeutics-president-and-ceo-howard-robin-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-in-san-francisco-ca-301713076.html

SOURCE Nektar Therapeutics

FAQ

What date and time is Nektar Therapeutics presenting at the J.P. Morgan Healthcare Conference?

Nektar Therapeutics is presenting on January 11, 2023, at 8:15 a.m. Pacific Time.

Where can I watch Nektar Therapeutics' presentation?

The presentation can be accessed via a Webcast on the Nektar Investor Events Calendar.

How long will the Nektar Therapeutics presentation replay be available?

The replay of the presentation will be available until February 11, 2023.

Who is the CEO of Nektar Therapeutics?

The CEO of Nektar Therapeutics is Howard Robin.

What is the main focus of Nektar Therapeutics?

Nektar Therapeutics specializes in biopharmaceuticals with a focus on oncology and immunology.